Clinical Trial: A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599410) titled 'A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus' on May 11.

Brief Summary: The aim of the trial is to investigate the efficacy and safety of HRS9531 tablets versus placebo in participants with type 2 diabetes mellitus who failed to achieve adequate glycemic control on lifestyle intervention alone or on a stable dose of metformin. This study will last 20 weeks.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: T2DM

Intervention: DRUG: HRS9531 Tablet

HRS9531 Tablet dose 1

DRUG: HRS9531 Tablet

HRS9531 Tablet dose 2

DRUG: HRS9531 Tablet

H...